DT
STRO icon

Diversified Trust’s Sutro Biopharma STRO Stock Holding History

Diversified Trust’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,261
Closed -$8.2K – 1002
2025
Q1 		$8.2K Hold
1,261
– – ﹤0.01% 917
2024
Q4 		$23.2K Sell
1,261
-42
-3% -$1.28K ﹤0.01% 913
2024
Q3 		$45.1K Hold
1,303
– – ﹤0.01% 893
2024
Q2 		$38.2K Hold
1,303
– – ﹤0.01% 856
2024
Q1 		$73.6K Buy
1,303
+184
+16% +$8.13K ﹤0.01% 804
2023
Q4 		$48K Hold
1,119
– – ﹤0.01% 849
2023
Q3 		$38.8K Hold
1,119
– – ﹤0.01% 811
2023
Q2 		$52K Buy
+1,119
New +$55.7K ﹤0.01% 810

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Diversified Trust's STRO Position: Q2 2025 in Review

Diversified Trust sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 1,261 shares — an estimated $8.2K sold.

Diversified Trust first reported a position in STRO in Q2 2023 and held it in 8 quarters. The position peaked at $73.6K in Q1 2024. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Diversified Trust reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Diversified Trust sold 1,261 Sutro Biopharma shares in Q2 2025, an estimated $8.2K.
  • Diversified Trust first reported a position in Sutro Biopharma in Q2 2023 and held it in 8 quarters.
  • Diversified Trust's Sutro Biopharma position peaked at $73.6K in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Diversified Trust's 13F filing for Q2 2025, filed 11 Jul 2025.